Laser Therapy in Managing Vaginal Prolapse
Laser Therapy in Managing Vaginal Prolapse
Efficacy of laser therapy in postmenopausal women with symptomatic prolapse stage >1.
 Assessment tools will include prolapse stage quantification system (POP-Q) and validated
 condition related questionnaires.
Postmenopausal women with symptomatic cystocele and/or rectocele stage 2 or 3 will be 1:1
 randomly allocated to Er:YAG laser or watchful waiting group. Participants in the Er:YAG
 laser group will receive laser therapies at monthly intervals, while participants in the
 watchful waiting group will receive no treatment. All outcomes in both groups will be
 evaluated at baseline, 4-months and 6-months from baseline.
Inclusion Criteria:

 -  Symptomatic prolapse stage >1 (cystocele, vaginal vault prolapse, enterocele,
 rectocele) according to POP-Q System

 -  Negative Pap-smear

 Exclusion Criteria:

 -  Asymptomatic prolapse

 -  prolapse stage <=1

 -  prolapse of uterus

 -  presence of any type of genital infections (i.e herpes, vaginitis etc)

 -  vaginal bleeding

 -  underlying pathologies that could interfere in patients compliance (i.e psychiatric)